Skip to Content

'
Clifton David Fuller, MD, PhD

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Associate Director of MR Programmatic Development, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Graduate Faculty, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX
Cross-Appointed Research Instructor, Oregon Health and Science University, Portland, OR

Bio Statement

My research focus remains development of evidence-based"personalized radiotherapy" techniques by incorporation of novelimaging methodologies. To date, the bulk of my work has focused on  improving multimodality (e.g. PET-CT, MRI,US) imaging for target delineation in the multi-institutional setting.

 

I have specific and singular expertise in imaging physicsand human imaging trial design, analysis and execution, acquired as part of myPhD and post-doctoral training. As a formal component of the MD Anderson K12Paul Calabresi Clinical Trial training program, in addition to directinstruction in clinical trial design and imaging informatics, I  have completed ABME board subspecialtycertification in Clinical Informatics in addition to primary ABR certificationin Radiation Oncology. As a radiation oncologist with informatics certificationand formal medical physics training, I am uniquely positioned to executeimage-guided radiotherapy clinical trials.

 

My long-term goal is to execute a practice-pattern changing,cooperative group-supported radiotherapy trial which incorporates aquantitative imaging biomarker for risk stratification, adaptive therapyplanning, and/or surrogate endpoint use in head and neck cancer.

Research Interests

My research focuses on development and implementation of multimodality imaging methodologies (CT/PET/MRI) for treatment stratification, target delineation, treatment delivery and response assessment in head and neck cancers.

Education & Training

Degree-Granting Education

2011 University of Texas Health Science Center At San Antonio, San Antonio, TX, PHD, Radiological Sciences (Human Imaging)
2006 University of Texas Health Science Center at San Antonio, San Antonio, TX, MD, Medicine
1998 Abilene Christian University, Abilene, TX, BS, Psychology/Biology (Pre-Medicine)

Postgraduate Training

2007-2011 Clinical Residency, Radiation Oncology, University of Texas Health Science Center at San Antonio, San Antonio, TX
2006-2007 Clinical Internship, Categorical, University Hospital/University of Texas Health Science Center at San Antonio, San Antonio, TX

Board Certifications

2015 American Board of Preventive Medicine (Clinical Informatics)
2013 American Board of Radiology

Honors and Awards

2013-present M. D. Anderson K12 Paul Calabresi Program in Clinical Oncology, National Cancer Institute
2011-2013 Coltman Fellowship Award, Hope Foundation
2011-2012 Young Investigator Award, American Society of Clinical Oncology Conquer Cancer Foundation
2010-2011 Clinical Research Loan Repayment (Renewal L30 CA136381-02), National Institutes of Health
2009 Annual Meeting Travel Grant, American Radium Society
2009 ESTRO Technology Transfer Grant, European Society for Therapeutic Radiology and Oncology, European Society of Radiation Oncology/Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis
2009 Travel Scholarship, University Hospital House Staff Council, University of Texas Health Science Center at San Antonio
2008-2010 Clinical Research Loan Repayment (L30 CA136381-01), National Institutes of Health
2008-2009 Product Development Support Grant, Society for Imaging Informatics in Medicine
2007-2009 Multidisciplinary Training Grant in Human Imaging (T32 EB000817), National Institute of Biomedical Imaging and Bioengineering
2007-2008 Research Travel Fellowship, European Association for Cancer Research
2007-2008 RSNA Research Resident/Fellow Grant (RR0732), Radiological Society of North America Research & Education Foundation
2007 Resident Travel Award, American Brachytherapy Society Annual Meeting
2007 Travel Scholarship, University Hospital House Staff Council, University of Texas Health Science Center at San Antonio
2005-2006 Carolyn L. Kuckein Memorial Medical Student Research Scholarship, Alpha Omega Alpha Medical Student Honor Society
2005 Annual Gastrointestinal Oncology Conference Travel Grant, International Society for Gastrointestinal Oncology
2005 Translational Research in Radiation Oncology Symposium Travel Grant, American Society of Therapeutic Radiology and Oncology
2004 First Place UTHSCSA Medical Student Research Day Poster Competition, Medical Dean's Office, University of Texas Health Science Center at San Antonio
2003-2004 Bartter Scholar, University of Texas Health Science Center at San Antonio/Frederic C. Bartter General Clinical Research Center
2003-2004 Mentored Medical Student Clinical Research Program Award, National Institutes of Health/National Center for Research Resources/Frederic C. Bartter General Clinical Research Center, University of Texas Health Science Center at San Antonio
2003-2004 Student Fellowship Grant, Society of Nuclear Medicine
2003 Medical Student Research Stipend Award,, American Cancer Society/Medical Dean's Office, University of Texas Health Science Center at San Antonio
2003 Outstanding Medical Student, Department of Radiation Oncology, University of Texas Health Science Center at San Antonio
2003 Travel Scholarship, 1st International Target Delineation Symposium for IMRT/3D CRT Treatment Planning, University of Texas M.D. Anderson Cancer Center
2002-2003 Medical Student Departmental Grant, Radiological Society of North America
2000 Medical Student Section Travel Grant, Texas Medical Association

Selected Publications

Peer-Reviewed Original Research Articles

1. Gunther JR, Liauw SL, Choi S, Mohamed AS, Thaker NG, Fuller CD, Stepaniak CJ, Das P, Golden DW. A Prostate Fossa Contouring Instructional Module: Implementation and Evaluation. J Am Coll Radiol 13(7):835-841.e1, 7/2016. e-Pub 5/2016. PMCID: PMC4935569.
2. Sio TT, Lin HK, Shi Q, Gunn GB, Cleeland CS, Lee JJ, Hernandez M, Blanchard P, Thaker NG, Phan J, Rosenthal DI, Garden AS, Morrison WH, Fuller CD, Mendoza TR, Mohan R, Wang XS, Frank SJ. Intensity Modulated Proton Therapy Versus Intensity Modulated Photon Radiation Therapy for Oropharyngeal Cancer: First Comparative Results of Patient-Reported Outcomes. Int J Radiat Oncol Biol Phys 95(4):1107-14, 7/2016. e-Pub 2/2016. PMID: 27354125.
3. Fuller CD, Mohamed AS, Garden AS, Gunn GB, Mulcahy CF, Zafereo M, Phan J, Lai SY, Lewin JS, Hutcheson KA, Frank SJ, Beadle BM, Morrison WH, El-Naggar AK, Kocak-Uzel E, Ginsberg LE, Kies MS, Weber RS, Rosenthal DI. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches. Head Neck. e-Pub 7/2016. PMID: 27466789.
4. Goepfert RP, Lewin JS, Barrow MP, Fuller CD, Lai SY, Song J, Hobbs BP, Gunn GB, Beadle BM, Rosenthal DI, Garden AS, Kies MS, Papadimitrakopoulou VA, Schwartz DL, Hutcheson KA. Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma. Laryngoscope. e-Pub 7/2016. PMID: 27440393.
5. Takiar V, Garden AS, Ma D, Morrison WH, Edson M, Zafereo ME, Gunn GB, Fuller CD, Beadle B, Frank SJ, William WN, Kies M, El-Naggar AK, Weber R, Rosenthal DI, Phan J. Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses. Int J Radiat Oncol Biol Phys 95(4):1117-31, 7/2016. e-Pub 3/2016. PMID: 27354127.
6. Garden AS, Fuller CD, Rosenthal DI, William WN, Gunn GB, Beadle BM, Johnson FM, Morrison WH, Phan J, Frank SJ, Kies MS, Sturgis EM. Reply to radiotherapy for human papillomavirus-positive oropharyngeal cancers in the National Cancer Data Base. Cancer. e-Pub 7/2016. PMID: 27420634.
7. Weygand J, Fuller CD, Ibbott GS, Mohamed AS, Ding Y, Yang J, Hwang KP, Wang J. Spatial Precision in Magnetic Resonance Imaging-Guided Radiation Therapy: The Role of Geometric Distortion. Int J Radiat Oncol Biol Phys 95(4):1304-16, 7/2016. e-Pub 3/2016. PMID: 27354136.
8. Jiang W, Mohamed AS, Fuller CD, Kim BY, Tang C, Gunn GB, Hanna EY, Frank SJ, Su SY, Diaz E, Kupferman ME, Beadle BM, Morrison WH, Skinner H, Lai SY, El-Naggar AK, DeMonte F, Rosenthal DI, Garden AS, Phan J. The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neck. Pract Radiat Oncol 6(4):241-7, Jul-Aug, 7/2016. e-Pub 11/2015. PMID: 26979544.
9. Grossberg AJ, Chamchod S, Fuller CD, Mohamed AS, Heukelom J, Eichelberger H, Kantor ME, Hutcheson KA, Gunn GB, Garden AS, Frank S, Phan J, Beadle B, Skinner HD, Morrison WH, Rosenthal DI. Association of Body Composition With Survival and Locoregional Control of Radiotherapy-Treated Head and Neck Squamous Cell Carcinoma. JAMA Oncol 2(6):782-9, 6/2016. e-Pub 2/2016. PMID: 26891703.
10. Grossberg AJ, Mohamed AS, Fuller CD. Cachexia in Radiotherapy-Treated Patients With Head and Neck Cancer-Reply. JAMA Oncol 2(6):831-2, 6/2016. PMID: 27281628.
11. Blanchard P, Garden AS, Gunn GB, Rosenthal DI, Morrison WH, Hernandez M, Crutison J, Lee JJ, Ye R, Fuller CD, Mohamed AS, Hutcheson KA, Holliday EB, Thaker NG, Sturgis EM, Kies MS, Zhu XR, Mohan R, Frank SJ. Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysis. Radiother Oncol. e-Pub 6/2016. PMID: 27342249.
12. Tucker JR, Xu L, Sturgis EM, Mohamed AS, Hofstede TM, Chambers MS, Lai SY, Fuller CD, Beadle B, Gunn GB, Hutcheson KA. Osteoradionecrosis in patients with salivary gland malignancies. Oral Oncol 57:1-5, 6/2016. e-Pub 3/2016. PMID: 27208837.
13. Garden AS, Fuller CD, Rosenthal DI, William WN, Gunn GB, Beadle BM, Johnson FM, Morrison WH, Phan J, Frank SJ, Kies MS, Sturgis EM. Radiation therapy (with or without neck surgery) for phenotypic human papillomavirus-associated oropharyngeal cancer. Cancer 122(11):1702-7, 6/2016. e-Pub 3/2016. PMCID: PMC4873387.
14. Holliday EB, Esmaeli B, Pinckard J, Garden AS, Rosenthal DI, Morrison WH, Kies MS, Gunn GB, Fuller CD, Phan J, Beadle BM, Zhu XR, Zhang X, Frank SJ. A Multidisciplinary Orbit-Sparing Treatment Approach That Includes Proton Therapy for Epithelial Tumors of the Orbit and Ocular Adnexa. Int J Radiat Oncol Biol Phys 95(1):344-52, 5/2016. e-Pub 8/2015. PMID: 26454680.
15. Gunn GB, Blanchard P, Garden AS, Zhu XR, Fuller CD, Mohamed AS, Morrison WH, Phan J, Beadle BM, Skinner HD, Sturgis EM, Kies MS, Hutcheson KA, Rosenthal DI, Mohan R, Gillin MT, Frank SJ. Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous Carcinoma. Int J Radiat Oncol Biol Phys 95(1):360-7, 5/2016. e-Pub 2/2016. PMID: 27084653.
16. Nien HH, Sturgis EM, Kies MS, El-Naggar AK, Morrison WH, Beadle BM, Johnson FM, Gunn GB, Fuller CD, Phan J, Gold KA, Frank SJ, Skinner H, Rosenthal DI, Garden AS, Fuller CD. Comparison of systemic therapies used concurrently with radiation for the treatment of human papillomavirus-associated oropharyngeal cancer. Head Neck 38 Suppl 1:E1554-61, 4/2016. e-Pub 11/2015. PMID: 26595157.
17. Bhattasali O, Holliday E, Kies MS, Hanna EY, Garden AS, Rosenthal DI, Morrison WH, Gunn GB, Fuller CD, Zhu XR, Frank SJ. Definitive proton radiation therapy and concurrent cisplatin for unresectable head and neck adenoid cystic carcinoma: A series of 9 cases and a critical review of the literature. Head Neck 38 Suppl 1:E1472-80, 4/2016. e-Pub 11/2015. PMID: 26561041.
18. Takiar V, Ma D, Garden AS, Li J, Rosenthal DI, Beadle BM, Frank SJ, Fuller CD, Gunn GB, Morrison WH, Hutcheson K, El-Naggar AK, Gold KA, Kupferman ME, Phan J. Disease control and toxicity outcomes for T4 carcinoma of the nasopharynx treated with intensity modulated radiotherapy. Head Neck 38 Suppl 1:E925-33, 4/2016. e-Pub 7/2015. PMID: 25994561.
19. Bishop AJ, Garden AS, Gunn GB, Rosenthal DI, Beadle BM, Fuller CD, Levy LB, Gillenwater AM, Kies MS, Esmaeli B, Frank SJ, Phan J, Morrison WH. Merkel cell carcinoma of the head and neck: Favorable outcomes with radiotherapy. Head Neck 38 Suppl 1:E452-8, 4/2016. e-Pub 7/2015. PMID: 25645649.
20. Tao R, Ma D, Takiar V, Frank SJ, Fuller CD, Gunn GB, Beadle BM, Morrison WH, Rosenthal DI, Edson MA, Esmaeli B, Kupferman ME, Hanna EY, Garden AS, Phan J. Orbital carcinomas treated with adjuvant intensity-modulated radiation therapy. Head Neck 38 Suppl 1:E580-7, 4/2016. e-Pub 7/2015. PMID: 25782700.
21. Edson MA, Garden AS, Takiar V, Glisson BS, Fuller CD, Gunn GB, Beadle BM, Morrison WH, Frank SJ, Shah SJ, Tao R, William WN, Weber RS, Rosenthal DI, Phan J. Outcomes for hypopharyngeal carcinoma treated with organ-preservation therapy. Head Neck 38 Suppl 1:E2091-9, 4/2016. e-Pub 2/2016. PMID: 26920665.
22. Jiang W, Chamberlain PD, Garden AS, Kim BY, Ma D, Lo EJ, Bell D, Gunn GB, Fuller CD, Rosenthal DI, Beadle BM, Frank SJ, Morrison WH, El-Naggar AK, Glisson BS, Sturgis EM, Phan J. Prognostic value of p16 expression in Epstein-Barr virus-positive nasopharyngeal carcinomas. Head Neck 38 Suppl 1:E1459-66, 4/2016. e-Pub 11/2015. PMID: 26560893.
23. Phan J, Sio TT, Nguyen TP, Takiar V, Gunn GB, Garden AS, Rosenthal DI, Fuller CD, Morrison WH, Beadle B, Ma D, Zafereo ME, Hutcheson KA, Kupferman ME, William WN, Frank SJ. Reirradiation of Head and Neck Cancers With Proton Therapy: Outcomes and Analyses. Int J Radiat Oncol Biol Phys. e-Pub 4/2016. PMID: 27325480.
24. Sandulache VC, Vandelaar LJ, Skinner HD, Cata J, Hutcheson K, Fuller CD, Phan J, Siddiqui Z, Lai SY, Weber RS, Zafereo ME. Salvage total laryngectomy after external-beam radiotherapy: A 20-year experience. Head Neck 38 Suppl 1:E1962-8, 4/2016. e-Pub 2/2016. PMID: 26879395.
25. Shoultz-Henley S, Garden AS, Mohamed AS, Sheu T, Kroll MH, Rosenthal DI, Gunn GB, Hayes AJ, French C, Eichelberger H, Kalpathy-Cramer J, Smith BD, Phan J, Ayoub Z, Lai SY, Pham B, Kies M, Gold KA, Sturgis E, Fuller CD. Prognostic value of pretherapy platelet elevation in oropharyngeal cancer patients treated with chemoradiation. Int J Cancer 138(5):1290-7, 3/2016. e-Pub 10/2015. PMCID: PMC4779600.
26. Messer JA, Mohamed AS, Hutcheson KA, Ding Y, Lewin JS, Wang J, Lai SY, Frank SJ, Garden AS, Sandulache V, Eichelberger H, French CC, Colen RR, Phan J, Kalpathy-Cramer J, Hazle JD, Rosenthal DI, Gunn GB, Fuller CD. Magnetic resonance imaging of swallowing-related structures in nasopharyngeal carcinoma patients receiving IMRT: Longitudinal dose-response characterization of quantitative signal kinetics. Radiother Oncol 118(2):315-22, 2/2016. e-Pub 1/2016. PMCID: PMC4794348.
27. Wang H, Wang C, Tung S, Dimmitt AW, Wong PF, Edson MA, Garden AS, Rosenthal DI, Fuller CD, Gunn GB, Takiar V, Wang XA, Luo D, Yang JN, Wong J, Phan J. Improved setup and positioning accuracy using a three-point customized cushion/mask/bite-block immobilization system for stereotactic reirradiation of head and neck cancer. J Appl Clin Med Phys 17(3):6038, 2016. e-Pub 5/2016. PMID: 27167275.
28. Wang J, Weygand J, Hwang KP, Mohamed AS, Ding Y, Fuller CD, Lai SY, Frank SJ, Zhou J. Magnetic Resonance Imaging of Glucose Uptake and Metabolism in Patients with Head and Neck Cancer. Sci Rep 6:30618, 2016. e-Pub 7/2016. PMID: 27461165.
29. Mohamed AS, Rosenthal DI, Awan MJ, Garden AS, Kocak-Uzel E, Belal AM, El-Gowily AG, Phan J, Beadle BM, Gunn GB, Fuller CD. Methodology for analysis and reporting patterns of failure in the Era of IMRT: head and neck cancer applications. Radiat Oncol 11(1):95, 2016. e-Pub 7/2016. PMID: 27460585.
30. Sandulache VC, Chen Y, Skinner HD, Lu T, Feng L, Court LE, Myers JN, Meyn RE, Fuller CD, Bankson JA, Lai SY. Acute Tumor Lactate Perturbations as a Biomarker of Genotoxic Stress: Development of a Biochemical Model. Mol Cancer Ther 14(12):2901-8, 12/2015. e-Pub 9/16/2015. PMCID: PMC4762176.
31. Wang J, Narang AK, Sugar EA, Luber B, Rosati LM, Hsu CC, Fuller CD, Pawlik TM, Miller RC, Czito BG, Tuli R, Crane CH, Ben-Josef E, Thomas CR, Herman JM. Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional Experience. Ann Surg Oncol 22 Suppl 3:1100-6, 12/2015. e-Pub 7/30/2015. PMID: 26224402.
32. Ding Y, Hazle JD, Mohamed AS, Frank SJ, Hobbs BP, Colen RR, Gunn GB, Wang J, Kalpathy-Cramer J, Garden AS, Lai SY, Rosenthal DI, Fuller CD. Intravoxel incoherent motion imaging kinetics during chemoradiotherapy for human papillomavirus-associated squamous cell carcinoma of the oropharynx: preliminary results from a prospective pilot study. NMR Biomed 28(12):1645-54, 12/2015. e-Pub 10/9/2015. PMCID: PMC4715635.
33. Lai SY, Fuller CD, Bhattacharya PK, Frank SJ. Metabolic Imaging as a Biomarker of Early Radiation Response in Tumors. Clin Cancer Res 21(22):4996-8, 11/15/2015. e-Pub 7/31/2015. PMCID: PMC4644683.
34. Holliday EB, Fuller CD, Kalpathy Cramer J, Gomez D, Rimner A, Li Y, Senan S, Wilson LD, Choi J, Komaki R, Thomas CR. Quantitative assessment of target delineation variability for thymic cancers: agreement evaluation of a prospective segmentation challenge, 11/2015.
35. Gunn GB, Hansen CC, Garden AS, Fuller CD, Mohamed AS, Morrison WH, Frank SJ, Beadle BM, Phan J, Chronowski GM, Sturgis EM, Lewis CM, Lu C, Hutcheson KA, Mendoza TR, Cleeland CS, Rosenthal DI. Favorable patient reported outcomes following IMRT for early carcinomas of the tonsillar fossa: Results from a symptom assessment study. Radiother Oncol 117(1):132-8, 10/2015. e-Pub 9/21/2015. PMCID: PMC4762263.
36. Sturgeon JD, Cox JA, Mayo LL, Gunn GB, Zhang L, Balter PA, Dong L, Awan M, Kocak-Uzel E, Mohamed AS, Rosenthal DI, Fuller CD. Improved human observer performance in digital reconstructed radiograph verification in head and neck cancer radiotherapy. Int J Comput Assist Radiol Surg 10(10):1667-73, 10/2015. e-Pub 12/5/2014. PMCID: PMC4801514.
37. Rosenthal DI, Fuller CD, Peters LJ, Thames HD. Final Report of Radiation Therapy Oncology Group Protocol 9003: Provocative, but Limited Conclusions From Exploratory Analyses. Int J Radiat Oncol Biol Phys 92(4):715-7, 7/15/2015. PMID: 26104925.
38. Holliday EB, Ahmed AA, Jagsi R, Stentz NC, Woodward WA, Fuller CD, Thomas CR. Pregnancy and Parenthood in Radiation Oncology, Views and Experiences Survey (PROVES): Results of a Blinded Prospective Trainee Parenting and Career Development Assessment. Int J Radiat Oncol Biol Phys 92(3):516-24, 7/2015. e-Pub 4/2015. PMID: 25892584.
39. Ding Y, Mohamed AS, Yang J, Colen RR, Frank SJ, Wang J, Wassal EY, Wang W, Kantor ME, Balter PA, Rosenthal DI, Lai SY, Hazle JD, Fuller CD. Prospective observer and software-based assessment of magnetic resonance imaging quality in head and neck cancer: Should standard positioning and immobilization be required for radiation therapy applications? Pract Radiat Oncol 5(4):e299-308, Jul-Aug, 7/2015. e-Pub 12/2014. PMCID: PMC4470880.
40. Rosenthal DI, Mohamed AS, Weber RS, Garden AS, Sevak PR, Kies MS, Morrison WH, Lewin JS, El-Naggar AK, Ginsberg LE, Kocak-Uzel E, Ang KK, Fuller CD. Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: A 3-decade survey. Cancer 121(10):1608-19, 5/2015. e-Pub 1/2015. PMCID: PMC4424158.
41. Awan M, Dyer BA, Kalpathy-Cramer J, Bongers E, Dahele M, Yang J, Walker GV, Thaker NG, Holliday E, Bishop AJ, Thomas CR, Rosenthal DI, Fuller CD. Auto-segmentation of the brachial plexus assessed with TaCTICS - A software platform for rapid multiple-metric quantitative evaluation of contours. Acta Oncol 54(4):1-5, 4/2015. e-Pub 10/2014. PMCID: PMC4801518.
42. Mohamed AS, Ruangskul MN, Awan MJ, Baron CA, Kalpathy-Cramer J, Castillo R, Castillo E, Guerrero TM, Kocak-Uzel E, Yang J, Court LE, Kantor ME, Gunn GB, Colen RR, Frank SJ, Garden AS, Rosenthal DI, Fuller CD. Quality Assurance Assessment of Diagnostic and Radiation Therapy-Simulation CT Image Registration for Head and Neck Radiation Therapy: Anatomic Region of Interest-based Comparison of Rigid and Deformable Algorithms. Radiology 274(3):132871, 3/2015. e-Pub 11/2014. PMCID: PMC4358813.
43. Tang C, Fuller CD, Garden AS, Awan MJ, Colen RR, Morrison WH, Frank SJ, Beadle BM, Phan J, Sturgis EM, Zafereo ME, Weber RS, Rosenthal DI, Gunn GB. Characteristics and kinetics of cervical lymph node regression after radiation therapy for human papillomavirus-associated oropharyngeal carcinoma: Quantitative image analysis of post-radiotherapy response. Oral Oncol 51(2):195-201, 2/2015. e-Pub 11/2014. PMCID: PMC4502963.
44. Roy A, Fuller CD, Rosenthal DI, Thomas CR. Comparison of measurement methods with a mixed effects procedure accounting for replicated evaluations (COM3PARE): method comparison algorithm implementation for head and neck IGRT positional verification. BMC Med Imaging 15:35, 2015. e-Pub 8/28/2015. PMCID: PMC4551570.
45. Garden AS, Gunn GB, Hessel A, Beadle BM, Ahmed S, El-Naggar AK, Fuller CD, Byers LA, Phan J, Frank SJ, Morrison WH, Kies MS, Rosenthal DI, Sturgis EM. Management of the lymph node-positive neck in the patient with human papillomavirus-associated oropharyngeal cancer. Cancer 120(19):3082-8, 10/2014. e-Pub 6/2014. PMCID: PMC4172550.
46. Sheu T, Fuller CD, Mendoza TR, Garden AS, Morrison WH, Beadle BM, Phan J, Frank SJ, Hanna EY, Lu C, Cleeland CS, Rosenthal DI, Gunn GB. Nomogram for Predicting Symptom Severity during Radiation Therapy for Head and Neck Cancer. Otolaryngol Head Neck Surg 151(4):619-26, 10/2014. e-Pub 8/2014. PMCID: PMC4184965.
47. Mavroidis P, Giantsoudis D, Awan MJ, Nijkamp J, Rasch CR, Duppen JC, Thomas CR, Okunieff P, Jones WE, Kachnic LA, Papanikolaou N, Fuller CD, Southwest Oncology Group Radiation Oncology Committee. Consequences of anorectal cancer atlas implementation in the cooperative group setting: Radiobiologic analysis of a prospective randomized in silico target delineation study. Radiother Oncol 112(3):418-24, 9/2014. e-Pub 7/2014. PMCID: PMC4258107.
48. Walker GV, Awan M, Tao R, Koay EJ, Boehling NS, Grant JD, Sittig DF, Gunn GB, Garden AS, Phan J, Morrison WH, Rosenthal DI, Mohamed AS, Fuller CD. Prospective randomized double-blind study of atlas-based organ-at-risk autosegmentation-assisted radiation planning in head and neck cancer. Radiother Oncol 112(3):321-5, 9/2014. e-Pub 9/2014. PMCID: PMC4252740.
49. Awan MJ, Mohamed AS, Lewin JS, Baron CA, Gunn GB, Rosenthal DI, Holsinger FC, Schwartz DL, Fuller CD, Hutcheson KA. Late radiation-associated dysphagia (late-RAD) with lower cranial neuropathy after oropharyngeal radiotherapy: A preliminary dosimetric comparison. Oral Oncol 50(8):746-52, 8/2014. e-Pub 6/2014. PMCID: PMC4158823.
50. Rosenthal DI, Mendoza TR, Fuller CD, Hutcheson KA, Wang XS, Hanna EY, Lu C, Garden AS, Morrison WH, Cleeland CS, Gunn GB. Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: A prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module. Cancer 120(13):1975-84, 7/2014. e-Pub 4/2014. PMCID: PMC4095802.
51. Kocak-Uzel E, Gunn GB, Colen RR, Kantor ME, Mohamed AS, Schoultz-Henley S, Mavroidis P, Frank SJ, Garden AS, Beadle BM, Morrison WH, Phan J, Rosenthal DI, Fuller CD. Beam path toxicity in candidate organs-at-risk: Assessment of radiation emetogenesis for patients receiving head and neck intensity modulated radiotherapy. Radiother Oncol 111(2):281-8, 5/2014. e-Pub 4/2014. PMCID: PMC4063998.
52. Holliday EB, Jagsi R, Wilson LD, Choi M, Thomas CR, Fuller CD. Gender differences in publication productivity, academic position, career duration, and funding among U.S. academic radiation oncology faculty. Acad Med 89(5):767-73, 5/2014. PMCID: PMC4378901.
53. Choi M, Holliday EB, Jagsi R, Wilson LD, Fuller CD, Thomas CR. Citation-based Estimation of Scholarly Activity Among Domestic Academic Radiation Oncologists: Five-Year Update. J Radiat Oncol 3(1):115-122, 3/2014. PMCID: PMC3963283.
54. Kalpathy-Cramer J, Awan M, Bedrick S, Rasch CR, Rosenthal DI, Fuller CD. Development of a Software for Quantitative Evaluation Radiotherapy Target and Organ-at-Risk Segmentation Comparison. J Digit Imaging 27(1):108-19, 2/2014. e-Pub 9/2013. PMCID: PMC3903974.
55. Holliday EB, Jagsi R, Thomas CR, Wilson LD, Fuller CD. Standing on the Shoulders of Giants: Results From the Radiation Oncology Academic Development and Mentorship Assessment Project (ROADMAP). Int J Radiat Oncol Biol Phys 88(1):18-24, 1/2014. e-Pub 11/2013. PMCID: PMC4085773.
56. Baron CA, Awan MJ, Mohamed AS, Akel I, Rosenthal DI, Gunn GB, Garden AS, Dyer BA, Court L, Sevak PR, Kocak-Uzel E, Fuller CD. Estimation of daily interfractional larynx residual setup error after isocentric alignment for head and neck radiotherapy: quality assurance implications for target volume and organs-at-risk margination using daily CT on- rails imaging. J Appl Clin Med Phys 16(1):5108, 2014. e-Pub 1/2014. PMID: 25679151.
57. Gunn GB, Mendoza TR, Fuller CD, Gning I, Frank SJ, Beadle BM, Hanna EY, Lu C, Cleeland CS, Rosenthal DI. High Symptom Burden Prior to Radiation Therapy for Head and Neck Cancer: A Patient-Reported Outcomes Study. Head Neck 35(10):1490-8, 10/2013. e-Pub 11/2012. PMCID: PMC3788079.
58. Gunn GB, Debnam JM, Fuller CD, Morrison WH, Frank SJ, Beadle BM, Sturgis EM, Glisson BS, Phan J, Rosenthal DI, Garden AS. The impact of radiographic retropharyngeal adenopathy in oropharyngeal cancer. Cancer 119(17):3162-9, 9/1/2013. e-Pub 6/3/2013. PMCID: PMC3775996.
59. Rana S, Holliday EB, Jagsi R, Wilson LD, Choi M, Thomas CR, Fuller CD. Scholastic activity among radiation oncology residents at US academic institutions: a benchmark analysis. J Cancer Educ 28(3):541-6, 9/2013. PMID: 23828146.
60. Awan M, Kalpathy-Cramer J, Gunn GB, Beadle BM, Garden AS, Phan J, Holliday E, Jones WE, Maani E, Patel A, Choi J, Clyburn V, Tantiwongkosi B, Rosenthal DI, Fuller CD. Prospective Assessment of an Atlas-Based Intervention Combined With Real-Time Software Feedback in Contouring Lymph Node Levels and Organs-at-Risk in the Head and Neck: Quantitative Assessment of Conformance to Expert Delineation. Pract Radiat Oncol 3(3):186193, 7/2013. PMCID: PMC3706296.
61. Awan M, Kalpathy-Cramer J, Gunn GB, Beadle BM, Garden AS, Phan J, Holliday E, Jones WE, Maani E, Patel A, Choi J, Clyburn V, Tantiwongkosi B, Rosenthal DI, Fuller CD. Prospective assessment of an atlas-based intervention combined with real-time software feedback in contouring lymph node levels and organs-at-risk in the head and neck: Quantitative assessment of conformance to expert delineation. Pract Radiat Oncol 3(3):186-93, Jul-Sep, 7/2013. e-Pub 12/2012. PMCID: PMC3706296.
62. Ramahi E, Choi J, Fuller CD, Eng TY. Merkel cell carcinoma. Am J Clin Oncol 36(3):299-309, 6/2013. PMCID: PMC3121923.
63. Holliday E, Fuller CD, Wilson LD, Thomas CR. Success Breeds Success: Authorship Distribution in the Red Journal 1975-2011. Int J Radiat Oncol Biol Phys 85(1):23-8, 1/2013. e-Pub 5/2012. PMID: 22560553.
64. Quigley MR, Holliday EB, Fuller CD, Choi M, Thomas CR. Distribution of the h-Index in Radiation Oncology Conforms to a Variation of Power Law: Implications for Assessing Academic Productivity. J Cancer Educ. e-Pub 4/2012. PMID: 22544537.
65. Fuller CD. Human-Computer Interaction in Radiotherapy Target Volume Delineation: A Prospective, Multi-institutional Comparison of User Input Devices. Journal of Digital Imaging 24(5):794-803, 10/2011. PMID: 20978922.
66. Wang SJ, Lemieux A, Kalpathy-Cramer J, Ord C, Walker G, Fuller CD, Kim JS, Thomas CR. A Nomogram for Predicting the Benefit of Adjuvant Chemoradiotherapy for Resected Gallbladder Cancer. Journal of Clinical Oncology, 2011.
67. Kalpathy-Cramer J, Bedrick SD, Boccia K, Fuller CD. A pilot prospective feasibility study of organ-at-risk definition using Target Contour Testing/Instructional Computer Software (TaCTICS), a training and evaluation platform for radiotherapy target delineation. AMIA Annu Symp Proc 2011:654-63, 2011. e-Pub 10/2011. PMCID: PMC3243186.
68. Wang SJ, Wissel AR, Luh JY, Fuller CD, Kalpathy-Cramer J, Thomas CR. An Interactive Tool for Individualized Estimation of Conditional Survival in Rectal Cancer. Annals of Surgical Oncology, 2011.
69. Ciura K, McBurney M, Nguyen B, Pham M, Rebueno N, Fuller CD, Guha-Thakurta N, Rosenthal DI. Effect of Brain Stem and Dorsal Vagus Complex Dosimetry on Nausea and Vomiting in Head and Neck Intensity Modulated Radiation Therapy. Med Dosim 36(1):41-5, 2011. e-Pub 1/2010. PMCID: PMC4510046.
70. Mesa F, Eng TY, Esquivel C, Fuller CD, Papanikolaou N, Sosa M. Implementation of a lateral total body irradiation technique with 6 MV photons. Journal of Radiotherapy in Practice, 2011.
71. Wang SJ, Wissel AR, Luh JY, Fuller CD, Kalpathy-Cramer J, Thomas CR. Individualized Estimation of Conditional Survival for Patients with Head and Neck Cancer. Annals of Surgical Oncology, 2011.
72. Jung AJ, Hardeman RL, Peng Q, Fuller CD, El-Merhi F, Dalrymple NC, Jung A. Prospective Multiparametric 3.0T Endorectal Prostate MRI Imaging Observations in Low-Grade Prostate Cancer. Cancer Investigations, 2011.
73. Fuller CD, Nijkamp J, Duppen J, Rasch CRN, Thomas CR, Wang SJ, Okunieff P, Jones WE, Baseman DB, Patel S, Demandante CGN, Harris AM, Smith BD, Katz AW, McGann C, Harper JL, Chang DT, Smalley S, Marshall DT, Goodman KA, Papanikolaou N, Kachnic LA. Prospective randomized double-blind pilot study of site-specific consensus atlas implementation for rectal cancer target volume delineation in the cooperative group setting,. Int J Radiat Oncol Biol Phys. 79(2):481-9, 2011.
74. Baluna R, Fuller CD, Eng TY, Thomas CR. Radiation-induced toxicity in cancer patients with low plasma fibronectin levels. Journal of Radiotherapy in Practice, 2011.
75. Rosenthal DI, Fuller CD, Barker JL, Mason B, Garcia JA, Lewin J, Holsinger FC, Stasney R, Frank SJ, Schwartz DL, Morrison WH, Garden AS, Ang KK. Simple Carotid-Sparing IMRT Technique and Preliminary Experience for T1-2 Glottic Cancer. Int J Radiat Oncol Biol Phys. 77(2):455-61, 6/2010. PMID: 19679406.
76. Zamboni BA, Yothers G, Choi M, Fuller CD, Dignam JJ, Raich PC, Thomas CR, O'Connell MJ, Wolmark N, Wang SJ. Conditional Survival and the Choice of Conditioning Set for Patients with Colon Cancer: An Analysis of NSABP Trials C-03 through C-07. Journal of Clinical Oncology 28(15):2544-8, 5/2010. PMCID: PMCPMC2881729.
77. Fuller CD, Thomas CR. Chemoradiation for Anal Cancer: The More Things Change, the More They Stay the Same. Oncology (Williston Park) 24(5):427-30, 2010.
78. Wang SJ, Kalpathy-Cramer J, Kim JS, Fuller CD, Thomas CR. Parametric Survival Models for Predicting the Benefit of Adjuvant Chemoradiotherapy in Gallbladder Cancer. American Informatics Association Annual Symposium Proceedings:847-851, 2010.
79. Fuller CD, Ramahi EH, Aherne N, Eng TY, Giaccone G, Thomas CR. Radiotherapy for Thymic Neoplasms. Journal of Thoracic Oncology(5):S327-335, 2010.
80. Kalpathy-Cramer J, Fuller CD. Target Contour Testing/Instructional Computer Software (TaCTICS): A Novel Training and Evaluation Platform for Radiotherapy Target Delineation. American Informatics Association Annual Symposium Proceedings:361-365, 2010.
81. Fuller CD, Scarbrough TJ, Sonke JJ, Rasch CRN, Choi M, Ting JY, Wang S, Papanikolaou N, Rosenthal DI. Method comparison of automated matching software assisted cone-beam CT and stereoscopic kilovoltage X-ray positional verification image-guided radiation therapy for head and neck cancer: a prospective analysis,. Physics in Medicine and Biology 54(24):7401-15, 12/2009. PMID: 19934488.
82. Fuller CD, Dang ND, Wang SJ, Desai P, Choi M, Thomas CR, Fuss M. Image-guided intensity-modulated radiotherapy (IG-IMRT) for biliary adenocarcinomas: Initial clinical results. Radiother Oncol 92(2):249-54, 8/2009. e-Pub 3/2009. PMID: 19324442.
83. Choi M, Fuller CD, Thomas CR. Estimation of citation-based scholarly activity among radiation oncology faculty at domestic residency-training institutions: 1996-2007. Int J Radiat Oncol Biol Phys 74(1):172-8, 5/2009. e-Pub 11/2008. PMID: 18990506.
84. Choi M, Fuller CD, Wang SJ, Siddiqi A, Wong A, Thomas CR, Fuss M. Effect of body mass index on shifts in ultrasound-based image-guided intensity-modulated radiation therapy for abdominal malignancies. Radiother Oncol 91(1):114-9, 4/2009. e-Pub 9/2008. PMID: 18804301.
85. Fuller CD, Choi M, Thomas CR. Bibliometric analysis of radiation oncology departmental scholarly publication productivity at domestic residency training institutions. J Am Coll Radiol 6(2):112-8, 2/2009. PMID: 19179240.
86. Fuller CD, Choi M, Thomas CR. Bibliometric analysis of radiation oncology departmental scholarly publication productivity at domestic residency-training institutions:1996-2007. Journal of the American College of Radiology 6(2):112-8, 2009.
87. Fuller CD, Dang N, Wang SJ, Desai P, Choi M, Thomas CR, Fuss M. Image-guided intensity modulated radiotherapy (IG-IMRT) for biliary adenocarcinomas:initial clinical results, Radiotherapy and oncology. journal of the European Society for Therapeutic Radiology and Oncology 92(2):249-54, 2009.
88. Fuller CD, Wang SJ, Choi M, Czito BG, Cornell J, Welzel T, McGlynn K, Luh J, Thomas CR. Multimodality therapy for locoregional extrahepatic cholangiocarcinoma: a population based analysis. Cancer 27(115):5175-5183, 2009.
89. Bleyer A, Choi M, Fuller CD, Thomas CR Jr, Wang SJ. Relative Lack of Conditional Survival Improvement in Adolescents and Young Adults with Cancer. Seminars in Oncology 36(5):460-467, 2009.
90. Okunieff P, Kachnic LA, Constine LS, Fuller CD, Gaspar LE, Hayes DF, Hooks J, Ling C, Meyskens FL, Phillip PA, Raben D, Smalley SR, Swanson GP, Teicher B, Thomas CR, Vikram B, Zelefsky MJ, Baker LH. Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG):Research Objectives Workshop 2008. Clinical Cancer Research 15(18):5663-70, 2009.
91. Rosenthal DI, Chambers MS, Fuller CD, Rebueno NC, Garcia J, Kies MS, Morrison WH, Ang KK, Garden AS. Beam Path Toxicities to Non-Target Structures during Intensity-Modulated Radiation Therapy for Head and Neck Cancers. Int J Radiat Oncol Biol Phys 72(3):747-755, 11/2008. e-Pub 5/2008. PMID: 18455324.
92. Fuller CD, Schillerstrom JE, Jones WE, Boersma M, Royall DR, Fuss M. Prospective Evaluation of Pretreatment Executive Cognitive Impairment and Depression in Patients Referred for Radiotherapy. Int J Radiat Oncol Biol Phys 72(2):529-533, 10/2008. e-Pub 4/2008. PMID: 18411001.
93. Fuller CD, Housman DM, Thomas CR. Radiotherapy for Thymoma and Thymic Carcinoma. Hematol Oncol Clin North Am 22(3):489-507, 6/2008. PMID: 18514129.
94. Choi M, Fuller CD, Thomas CR, Wang SJ. Conditional survival in ovarian cancer: results from the SEER dataset 1988-2001. Gynecol Oncol 109(2):203-9, 5/2008. e-Pub 3/2008. PMID: 18329082.
95. Wang SJ, Fuller CD, Kim JS, Sittig DF, Thomas CR, Ravdin PM. Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer. J Clin Oncol 26(13):2112-7, 5/2008. e-Pub 3/2008. PMID: 18378567.
96. Wang SJ, Fuller CD, Choi M, Thomas CR. A cost-effectiveness analysis of adjuvant chemoradiotherapy for resected gastric cancer. Gastrointest Cancer Res 2(2):57-63, 3/2008. PMCID: PMC2630819.
97. Wang SJ, Fuller CD, Choi M, Thomas CR. A Cost-Effectiveness Analysis of Adjuvant Chemoradiation Therapy for Gastric Cancer. Gastrointestinal Cancer Research 2(2):57-63, 2008.
98. Wang SJ, Fuller CD, Kim JS, Sittig DF, Thomas CR, Ravdin P. A Prediction Model for Estimating the Survival Benefit of Adjuvant Radiotherapy. Am J Clin Oncol 26(13):2112-7, 2008.
99. Choi M, Fuller CD, Siddiqi A, Wong A, Thomas CR, Fuss M. Effects of Body Mass Index on Shifts in Ultrasound-Based Image-Guided Intensity-Modulated Radiation Therapy for Abdominal Malignancies. Radiat Oncol 91(1):114-9, 2008.
100. Bleyer A, Choi M, Wang SJ, Fuller CD, Raney RB, Thomas CR. Increased vulnerability of the spinal cord to radiation and intrathecal chemotherapy during adolescence: A report from the Children's Oncology Group,. Pediatric Blood & Cancer 53(7):1205-1210, 2008. PMID: 19821538.
101. Eng TY, Boersma MG, Fuller CD, Goytia V, Jones WE, Joyner M, Nguyen DD. A comprehensive review of the treatment of Merkel cell carcinoma. Am J Clin Oncol 30(6):624-36, 12/2007. PMID: 18091058.
102. Wang SJ, Choi M, Fuller CD, Salter BJ, Fuss M. Intensity-modulated Radiosurgery for patients with brain metastases: a mature outcomes analysis. Technol Cancer Res Treat 6(3):161-8, 6/2007. PMID: 17535023.
103. Wang SJ, Fuller CD, Emery R, Thomas CR. Conditional Survival in Rectal Cancer: A SEER Database Analysis. Gastrointest Cancer Res 1(1):84, 5/2007. PMCID: PMC2632815.
104. Fuller CD, Wang SJ, Thomas CR, Hoffman HT, Weber RS, Rosenthal DI. Conditional survival in head and neck squamous cell carcinoma: results from the SEER dataset 1973-1998. Cancer 109(7):1331-43, 4/2007. PMID: 17326199.
105. Wang SJ, Fuller CD, Thomas CR. Ethnic disparities in conditional survival of patients with non-small cell lung cancer. J Thorac Oncol 2(5):180-90, 3/2007. PMID: 17410040.
106. Fuss M, Wong A, Fuller CD, Salter BJ, Fuss C, Thomas CR. Image-guided intensity-modulated radiotherapy for pancreatic carcinoma. Gastrointest Cancer Res 1(1):2-11, 1/2007. PMCID: PMC2632515.
107. Wang SJ, Emery R, Fuller CD, Kim JS, Sittig DF, Thomas CR. Conditional survival in gastric cancer: a SEER database analysis. Gastric Cancer 10(3):153-8, 2007. e-Pub 9/2007. PMID: 17922092.
108. Fuller CD, Choi M, Forthuber B, Wang SJ, Rajagiriyil N, Salter BJ, Fuss M. Standard fractionation intensity modulated radiation therapy (IMRT) of primary and recurrent glioblastoma multiforme. Radiat Oncol 14(2):26, 2007. e-Pub 7/2007. PMCID: PMC1939706.
109. Marks L, Fuller CD, Sangvi P, Pinn M, Thomas CR Jr. Update on the Rheumatologic Manifestations of Malignancy. Current Cancer Therapy Reviews 3(3):215-222, 2007.
110. Lai LL, Fuller CD, Kachnic LA, Thomas CR. Can pelvic radiotherapy be omitted in select patients with rectal cancer? Semin Oncol 33(6 Suppl 11):S70-4, 12/2006. PMID: 17178292.
111. Fuller CD, Thomas CR, Wong A, Cavanaugh SX, Salter BJ, Herman TS, Fuss M. Image-guided intensity-modulated radiation therapy for gallbladder carcinoma. Radiother Oncol 81(1):65-72, 10/2006. e-Pub 9/2006. PMID: 16971012.
112. Fuller CD, Thomas CR, Schwartz S, Golden N, Ting J, Wong A, Erdogmus D, Scarbrough TJ. Method comparison of ultrasound and kilovoltage x-ray fiducial marker imaging for prostate radiotherapy targeting. Phys Med Biol 51(19):4981-93, 10/2006. e-Pub 9/2006. PMID: 16985282.
113. Scarbrough TJ, Golden NM, Ting JY, Fuller CD, Wong A, Kupelian PA, Thomas CR. Comparison of ultrasound and implanted seed marker prostate localization methods: Implications for image-guided radiotherapy. Int J Radiat Oncol Biol Phys 65(2):378-87, 6/2006. e-Pub 3/2006. PMID: 16563658.
114. Eng TY, Boersma MK, Fuller CD, Luh JY, Siddiqi A, Wang S, Thomas CR. The role of radiation therapy in benign diseases. Hematol Oncol Clin North Am 20(2):523-57, 4/2006. PMID: 16730305.
115. Rosenthal DI, Fuller CD, Machtay M, Algazy KM, Meyer DM, Kaiser LR, Yardley DA, Loiacano ME, Carbone DP. Phase I study of Paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced non-small cell lung cancer. J Thorac Oncol 1(1):38-45, 1/2006. PMID: 17409825.
116. Jones K, Fuller CD, Luh JY, Childs CC, Miller AR, Tolcher AW, Herman TS, Thomas CR. Case report and summary of literature: giant perineal keloids treated with post-excisional radiotherapy. BMC Dermatol 6:7, 2006. e-Pub 4/2006. PMCID: PMC1562439.
117. Rassiah-Szegedi P, Salter BJ, Fuller CD, Blough M, Papanikolaou N, Fuss M. Monte Carlo characterization of target doses in stereotactic body radiation therapy (SBRT). Acta Oncol 45(7):989-94, 2006. PMID: 16982568.
118. Esquivel C, Fuller CD, Waggener RG, Wong A, Meltz M, Blough M, Eng TY, Thomas CR. Novel low-kVp beamlet system for choroidal melanoma. Radiat Oncol 1:36, 2006. e-Pub 9/2006. PMCID: PMC1586203.
119. Fuller CD, Thomas CR, Voeltz L, Salter BJ, Fuss M. Thermo-luminescent dosimeter evaluation of extra-target dose in intensity modulated sequential tomotherapy for pancreatic cancer. Journal of Radiotherapy in Practice 5(3):173-176, 2006.
120. Luh JY, Eng TY, Fuller CD. Minimizing urinary bladder radiation dose during brachytherapy for carcinoma of the cervix using balloon inflation technique: In regard to Malaker et al. (Int J Radiat Oncol Biol Phys 2005;61:257-266). Int J Radiat Oncol Biol Phys 62(3):944; author reply 944-5, 7/2005. PMID: 15936589.
121. Garcia JA, Bhakta S, Fuller CD, Thomas CR. Multidisciplinary approach to superior sulcus tumors. Cancer J 11(3):189-97, May-Jun, 5/2005. PMID: 16053660.
122. Koshy MC, Landry JC, Cavanaugh SX, Fuller CD, Willett CG, Abrams RA, Hoffman JP, Thomas CR. A challenge to the therapeutic nihilism of ESPAC-1. Int J Radiat Oncol Biol Phys 61(4):965-6, 3/15/2005. PMID: 15752874.
123. Cavanaugh SX, Fuller CD, Kupelian PA, Reddy C, Bradshaw P, Pollock BH, Fuss M. Time and PSA threshold model prognosticates long-term overall and disease-specific survival in prostate cancer patients as early as 3 months after external beam radiation therapy. Prostate Cancer Prostatic Dis 8(4):353-8, 2005. PMID: 16158079.
124. Eng TY, Naguib M, Fuller CD, Jones WE, Herman TS. Treatment of recurrent Merkel cell carcinoma: an analysis of 46 cases. Am J Clin Oncol 27(6):576-83, 12/2004. PMID: 15577435.
125. Eng TY, Boersma MG, Fuller CD, Cavanaugh SX, Valenzuela F, Herman TS. Treatment of merkel cell carcinoma. Am J Clin Oncol 27(5):510-5, 10/2004. PMID: 15596922.
126. Fuss M, Salter BJ, Cavanaugh SX, Fuss C, Sadeghi A, Fuller CD, Ameduri A, Hevezi JM, Herman TS, Thomas CR. Daily ultrasound-based image-guided targeting for radiotherapy of upper abdominal malignancies. Int J Radiat Oncol Biol Phys 59(4):1245-56, 7/2004. PMID: 15234062.
127. Cavanaugh SX, Kupelian PA, Fuller CD, Reddy C, Bradshaw P, Pollock BH, Fuss M. Early prostate-specific antigen (PSA) kinetics following prostate carcinoma radiotherapy: prognostic value of a time-and-PSA threshold model. Cancer 101(1):96-105, 7/2004. PMID: 15221994.
128. Fuller CD, Diaz I, Cavanaugh SX, Eng TY. In vivo dose perturbation effects of metallic dental alloys during head and neck irradiation with intensity modulated radiation therapy. Oral Oncol 40(6):645-8, 7/2004. PMID: 15063394.
129. Eng TY, Fuller CD, Jagirdar J, Bains Y, Thomas CR. Thymic carcinoma: state of the art review. Int J Radiat Oncol Biol Phys 59(3):654-64, 7/2004. PMID: 15183468.
130. Eng TY, Fuller CD, Cavanaugh SX, Blough MM, Sadeghi A, Herman T. Significant rectal and bladder dose reduction via utilization of Foley balloon catheters in high-dose-rate tandem and ovoid intracavitary brachytherapy of the uterine cervix. Int J Radiat Oncol Biol Phys 59(1):174-8, 5/2004. PMID: 15093914.
131. Eng TY, Naguib M, Galang T, Fuller CD. Retrospective study of the treatment of urethral cancer. Am J Clin Oncol 26(6):558-62, 2003.
132. Hamilton ML, Guo Z, Fuller CD, Van Remmen H, Ward WF, Austad SN, Troyer DA, Thompson I, Richardson A. A reliable assessment of 8-oxo-2-deoxyguanosine levels in nuclear and mitochondrial DNA using the sodium iodide method to isolate DNA. Nucleic Acids Res 29(10):2117-26, 5/2001. PMCID: PMC55450.

Invited Articles

1. Fuller CD. Multidisciplinary management of head and neck cancer. Head & Neck, DOI:10.1002/hed.23179. In Press.

Editorials

1. Fuller CD, Nijkamp J, Rasch CRN, Duppen J, Kachnic L, Okunieff P, Marshall D, Katz AW, Smith BD, Thomas CR. Impact of rectal cancer target volume consensus atlas implementation in the cooperative group setting: Preliminary results from a prospective randomized double-blind pilot study, 2010 Gastrointestinal Cancers Symposium. ASCO, 2010.
2. Lai LL, Fuller CD, Kachnic LA, Thomas CR. Can pelvic radiotherapy be omitted in select patients with rectal cancer? Seminars in oncology 33(6 Suppl 11):S70-4, 12/2006.
3. Koshy MC, Landry JC, Cavanaugh SX, Fuller CD, Willett CG, Abrams RA, Hoffman JP, Thomas CR Jr. A challenge to the therapeutic nihilism of ESPAC-1. International Journal of Radiation Oncology, Biology, Physics 61(4):965-6, 3/2005.
4. Fuller CD, Braden CJ, Thomas CR Jr. Quality of life: from a Tower of Babel toward a unified voice. International Journal of Radiation Oncology*Biology*Physics 58(5):1334-5, 4/2004.

Abstracts

1. Cardenas C, Wong A, Mohamed A, Yang J, Court L, Rao A, Fuller CD, Aristophanous M. SU-C-BRA-05: Delineating high-dose clinical target volumbes for head and neck tumors using machine learning algorithms. Medical Physics, 6/2016.
2. Ding Y, Mohamed A, Ma J, Frank SJ, Wang J, Fuller CD. SU-G-IeP1-05: Diffusion kurtosis imaging for oropharyngeal cancer detection, 6/2016.
3. Ger R, Awan M, Mohamed A, Ding Y, Frank SJ, Howell R, Li H, Liu H, Mohan R, Schellingerhout D, Stafford R, Wang J, Fuller CD, Court L. WE-FG-202-12: Investigation of longitudinal salivary gland DCE-MRI changes. Medical Physics, 6/2016.
4. Ho JC, Allen PK, Bhosale P, Rauch GM, Fuller CD, Mohamed A, Frumovitz M, Jhingran A, Eifel P, Klopp AH. Functional imaging predictors of outcome in cervical cancer following chemoradiation, 5/2016.
5. Mohamed AS, Rosenthal DI, Awan MJ,. et al. analysis and reporting patterns of failure in the era of imrt: head and neck cancer applications. Radiotherapy and Oncology, 4/2016.
6. Hansen CC, Chrane K, Gunn GB, Mohamed ASR, Rosenthal DI, Wefel JS, Phan J, Frank SJ, Garden AS, Smith B, Eichelberger H, Anderson C, McCoy C, Horiates M, Patrick C, Floris S, French C, Beadle BM, Morrison WH, Su SY, Hanna EY, Lewis CM, Skinner HD, Lai S, Fuller CD. Cognitive function and patient-reported memory problem following radiation therapy for cancers at the skull base: A survivorship study using the telephone interview for gognitive status and the MDASI-HN. Int J Radiat Oncol Biol Phys, 3/2016.
7. Phan J, Brown P, Nandita GT, Rosenthal D, Garden A, Gunn GB, Fuller CD, Li J, Ghia A, Yang J, Luo D, Su S, Hanna E, DeMonte F. Gamma knife stereotactic radiosurgery for trigeminal neuralgia secondary to recurrent skull base malignancies, 3/2016.
8. Hutcheson KA, Lin H, Yuk MM, Hubbard RM, Barrow MP, Gunn GB, Fuller CD, Garden AS, Lai S, Schwartz DL, Kies MS, Hanna EY, Goepfert RP, Lewin JS. Lower cranial neuropathy after oropharyngeal intensity modulated radiation therapy (IMRT): A prospective study and literature review. Int J Radiat Oncol Biol Phys, 3/2016.
9. Mohamed ASR, Shoultz Henley S, Garden AS, Sheu T, Kroll M, Rosenthal DI, Gunn GB, Phan J, Lai S, Kies MS, Gold KA, Sturgis EM, Fuller CD. Pretreatment complete blood count improves prognostic model survival prediction in oropharynageal cancer patients trwated with radiation therapy. Int J Radiat Oncol Biol Phys 94(4):964, 3/2016.
10. Goepfert RP, Lewin JS, Barrow MP, Gunn GB, Fuller CD, Beadle BM, Garden AS, Rosenthal DI, Kies MS, Papadimitrakopoulou S, Lai S, Schwartz DL, Hutcheson KA. Prospective MD Anderson dysphagia inventory outcomes after nonsurgical treatment of locoregionally advanced oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 3/2016.
11. Bongers EM, Dahele M, Kalpathy-Cramer J, Fuller CD, Senan S. Variation in contouring normal organs for stereotactic ablative radiotherapy: training analysis with an interactive software tool (TaCTICS)World Conference on Lung Cancer. International Association for the Study of Lung Cancer, 2011.
12. Walker GV, Fuller CD, Thomas CR, Wang SJ. A cost analysis of mitomycin-based versus cisplatin-based definitive chemoradiotherapy for anal cancer, 2010 Gastrointestinal Cancers Symposium. American Society of Clinical Oncology, 2010.
13. Wang SJ, Walker GV, Kalpathy-Cramer J, Kim JS, Fuller CD, Thomas CR Jr. A regression model decision aid for determining the benefit of adjuvant chemoradiotherapy for gallbladder cancer, 2010 Gastrointestinal Cancers Symposium. American Society of Clinical Oncology, http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=72&abstractID=2171, 2010.
14. Fuller CD, Rasch CRN, Duppen J, Papanikolaou N, Steenbakkers R, Thomas CR Jr, Wang SJ, Fuss M. Human-Computer Interaction in Radiotherapy Target Volume Delineation: A Prospective, Multi-Institutional Comparison of Mouse and Graphical Tablet User Input Devices, PROGRAM OF THE XVIth ICCR. International Conference on the Use of Computers in Radiation Therapy, 2010.
15. Fuller CD, Nijkamp J, Rasch CRN, Duppen J, Kachnic L, Okunieff P, Marshall D, Katz AW, Smith BD, Thomas CR. Impact of rectal cancer target volume consensus atlas implementation in the cooperative group setting: Preliminary results from a prospective randomized double-blind pilot study., 2010 Gastrointestinal Cancers Symposium. American Society of Clinical Oncology, 2010.
16. Fuller CD, Duppen J, Rasch CRN, Fuss M, Thomas CR Jr, Wang SJ, Papanikolaou N. Pen/Tablet Human-Computer Interface Reduces Radiation Oncologist Head and Neck Cancer Case Contouring Time: Preliminary Results From A Prospective Multi-Institutional Target Volume Delineation Study, SIIM Annual Meeting 2010,. Society for Imaging Informatics in Medicine, 2010.
17. Fuller CD, Kalpathy-Cramer J, Duppen J, Rasch CRN. Target Contour Testing/Instructional Computer Software (TaCTICS): A Novel Training and Quantitative Evaluation Software Platform for Radiotherapy Target Delineation, SIIM Annual Meeting 2010. Society for Imaging Informatics in Medicine, 2010.
18. Aherne NJ, Wood M, Herden JP, Mincham S, Last A, Hill JD, Fuller CD, Roy A, Shakespeare TP. Fiducial based target definition in patients undergoing salvage IMRT following prostatectomy. Asian Oncology Summit, 2009.
19. Fuller CD, Fullerton G, Duppen J, Thomas CR, Fuss M, Rosenthal DI, Scarbrough T, Sttenbakkers R, Rasch CRN. Human-Computer Interface Differentials in Radiotherapy Target Delineation: A Multi-Institutional Protocol, Training Grantees Meeting. National Institute of Biomedical Imaging and BioEngineering, 2008.
20. Shapiro R, Fuller CD, Eng TY. A Preliminary Analysis of Twenty-three Patients with Endometrial Cancer Treated with Primary High Dose Rate Brachytherapy. American Brachytherapy Society 2007 Annual Meeting, 2007.
21. Han XY, Gu T, Imanbayev G, Tee T, Ferris N, Han HY, Fuller CD, Hui L, Ashraf M, Sahn DJ. Cardiac Twist Quantification in Novel in Vitro Porcine LV Model by Tissue Doppler and 2D Speckle Tracking: A Comparison in Accuracy and Precision. American Society of Echocardiography 8th Annual Scientific Sessions, 2007.
22. Jones WE III, Fuller CD, Papanikolaou N. Comparison of ultrasound (US) and megavoltage CT (MVCT) prostate iamge-guided radiotherapy (IGRT) systematic and random set-up error components. Translational Research in Radiation Oncology and Radiobiology Symposium, 2007.
23. Kim E, Wang SJ, Fuller CD, Thomas CR. Conditional Survival for Patients with Thymic Carcinoma from the SEER Database. American Thoracic Society International Conference (Abstract No. 5420), 2007.
24. Wang SJ, Fuller CD, Scarbrough TS, Thomas CR. cost-effectiveness analysis of SWOG 9008: Adjuvant chemoradiation therapy for gastric cancer. Gastrointestinal Cancers Symposium (Abstract No. 36), 2007.
25. Wang SJ, Luh JY, Fuller CD, Thomas CR. Geographic variation in conditional survival for breast cancer patients: a SEER database analysis (Abstract 6058). San Antonio Breast Cancer Symposium, 2007.
26. Fuller CD, Starling GD, Wong A, Thomas CR, Fuss M. Image-guided intensity modulated radiation therapy (IG-IMRT) for extrahepatic cholangiocarcinoma, European Cancer Conference (ECCO14). European Cancer Organisation/Federation of European Cancer Societies, 2007.
27. Fuller CD, Scarbrough TJ, Choi M, Ting J. Image-guided radiation therapy (IGRT) for head and neck cancer: method comparison analysis of cone-beam CT (CBCT) and stereoscopic kV X-ray (KVX) positional verification. Translational Research in Radiation Oncology and Radiobiology Symposium, 2007.
28. Choi M, Fuller CD, Fuss M, Thomas CR. Ultrasound image guidance for abdominal malignancies: Set-up error and body mass index. Translational Research in Radiation Oncology and Radiobiology Symposium, 2007.
29. Wang SJ, Fuller CD, Scarbrough TJ. A Cost-Effectiveness Analysis of SWOG 9008: Adjuvant Chemoradiation Therapy for Gastric Cancer, Health Services/Outcomes Research in Radiation Oncology Symposium. American Society for Therapeutic Radiology and Oncology, #17, 2006.
30. Wang SJ, Fuller CD, Luh JY, Hundahl S, Karpeh MS, Thomas CR. An analysis from the SEER database of conditional survival for gastric cancer. Gastrointestinal Cancers Symposium, (Abstract No. 25), 2006.
31. Fuller CD. Basic, Translational and Clinical Radiation Oncology Research: Avenues of Exploration in Biology, Physics, and Patient Care. Abilene Christian University Math/Science Centennial Conference, 2006.
32. Fuller CD. Liberation medicine in the Christian university, Theology in the Christian University: Prospects for the 21st Century Conference. Abilene Christian University, 2006.
33. Fuller CD, Scarbrough T, Wong A, Ting J, Golden NM, Kupelian P, Thomas CR. Method Comparison Analysis of Ultrasound and Fiducial Marker Based Prostate Localization. 2006 Prostate Cancer Symposium, (Abstract No. 81), 2006.
34. Wang SJ, Fuller CD, Luh JY, Thomas CR, Bleyer WA. Older Adolescents and Young Adults with Cancer: Conditional Survival Deficit, Health Services/Outcomes Research in Radiation Oncology Symposium. American Society for Therapeutic Radiology and Oncology, #16, 2006.
35. Fuller CD, Kupelian P, Cavanaugh SX, Fuss M. Post-Therapy Disease Specific Survival May Be Predicted As Early As Three Months Post-Radiotherapy: Exploratory Recursive Partitioning Analysis (RPA) of PSA Time-to-Threshold (TTT) Risk Stratification and Model Verification,. Prostate Cancer Symposium, (Abstract No. 205), 2006.
36. Scarbrough TS, Ting J, Wang S, Fuller CD, Thomas CR. Simulated and Measured Analyses of Spheroprobability and Three Dimensional Setup Error. Radiological Society of North America Annual Meeting (Abstract SSA18-06), 2006.
37. Siddiqi A, Fuller CD, Wong A, Thomas Cr, Fuss M. Ultrasound image guidance for abdominal malignancies: Impact of body habitus on positional shifts. Gastrointestinal Cancers Symposium, 2006.
38. Joyner M, Fuller CD, Zubyk S, Wang S, Kahlenberg M, Rousseau DP, Thomas CR. Altered Fractionation Chemoradiotherapy in the Treatment of Locally Advanced Rectal Cancer: Experience of the San Antonio Cancer Institute. Radiological Society of North America Annual Meeting (LPR10-01 ), 2005.
39. Luh JY, Cummins SP, Baacke D, Fuller CD, Eng TY. Application of the inverse square law using the Bard catheter stylet to optimize balloon placement for intracavitary high-dose-rate tandem and ovoid brachytherapy of the uterine cervix. American Society of Therapeutic Radiology and Oncology Translational Research in Radiation Oncology Symposium, 2005.
40. Baluna R, Eng TY, Fuller CD, Thomas CR. Changes in plasma fibronectin levels as possible prognostic marker in non-small cell lung cancer. 11th World Conference on Lung Cancer, 2005.
41. Fuller CD, Wang SJ, Thomas CR. Conditional survival of gallbladder adenocarcinoma: Analysis from the SEER database. Gastrointestinal Cancers Symposium, (Abstract No. 158), 2005.
42. Baluna R, Fuller CD, Eng TY, Thomas CR. Extracellular matrix proteins modulate the effects of ionizing radiation in neuroblastoma cells. American Society of Therapeutic Radiology and Oncology Translational Research in Radiation Oncology Symposium, 2005.
43. Starling GD, Fuller CD, Thomas CR, Fuss M. Image-guided intensity modulated radiation therapy (IG-IMRT) affords increased survival for biliary tract tumors compared with conventional radiotherapy (RT): results from preliminary analysis. American Medical Association 4th Annual Interim Meeting Medical Student Research Symposium, 2005.
44. Fuller CD, Thomas CR, Wong A, Salter BJ, Herman TS, Fuss M. Image-guided intensity modulated radiation therapy for gallbladder cancer. 2nd International Congress on Gastrointestinal Oncology, 2005.
45. Fuss M, Fuller CD, Thomas CR. Image-guided tomotherapeutic intensity-modulated radiation therapy (IG-IMRT) for hepatocellular carcinoma. 2nd International Congress on Gastrointestinal Oncology, 2005.
46. Fay M, Fuller CD, Natarajan M, Thomas CR, Mooberry S. In-Vitro Radiopotentiation Capabilities of Novel Microtubule Inhibitor. American Medical Association 4th Annual Interim Meeting Medical Student Research Symposium, 2005.
47. Fuller CD. Liberation medicine in the Christian university, and its implications, Theology in the Christian University. Prospects for the 21st Century Conference, 2005.
48. Fuller CD, Scarbrough TJ, Golden NM, Wong A, Ting J, Kupelian P, Thomas CR. Limits of agreement analysis of ultrasound and fiducial marker-based prostate localization. American Society of Therapeutic Radiology and Oncology Translational Research in Radiation Oncology Symposium, 2005.
49. Fuller CD, Scarbrough T, Wong A, Ting J, Golden N, Thomas CR. Limits of agreement analysis of ultrasound and fiducial marker-based prostate localization. MD Anderson Young Investigators Research Forum, 2005.
50. Fuller CD. NIH/NCRR/GCRC Mentored Medical Student Program: Opportunities in Research for Medical Students. UTHSCSA Student Research Colloquium, 2005.
51. Joyner M, Fuller CD, Boersma M, Henye K, Thomas CR. Prophylactic Concomitant Pyroxidine Administration with Capecitabine (Xeloda) in the Treatment of Upper Gastrointestinal Tract Adenocarcinoma Receiving Radiation Therapy (RT) Ameliorates Hand-Foot Syndrome: Preliminary Experience from the San Antonio Canc. Radiological Society of North America Annual Meeting 2005, (LPR10-04),, 2005.
52. Kordy K, Fuller CD, Eng TY, Thomas CR. Quality of Life Measures in Hispanic Women Undergoing Radiotherapy for Breast Cancer is Directly Associated to Spirituality. American Medical Association 4th Annual Interim Meeting Medical Student Research Symposium, 2005.
53. Fuller CD, Wong A, Thomas CR, Cavanaugh SX, Salter BJ, Fuss M. Target volume reduction and spatial translocation in the treatment of primary cancers of the gallbladder by daily ultrasound image-guided intensity modulated radiation therapy (IG-IMRT), American Association for Cancer Research Annual Meeting 2005,(Abstract #1237). Proc Amer Assoc Cancer Res, AACR Meeting Abstracts: 287-c, 2005.
54. Wong A, Fuller CD, Thomas CR, Salter BJ, Fuss M. Preliminary Clinical Analysis of Daily Ultrasound-based Image-guided Radiotherapy (US-IGRT) for the Treatment of Pancreatic Carcinoma. Radiological Society of North America Annual Meeting (SSQ18-09), 2004.
55. Cavanaugh SX, Fuller CD, Voeltz L, Salter BJ, Fuss M. Acute toxicity in prostate cancer patients treated by high dose IMRT. American Association for Cancer Research Annual Meeting, 2003.
56. Fuller CD, Diaz I, Eng TY. Dose Perturbation Effects of Metallic Dental Alloys in Head and Neck Irradiation Using Intensity Modulated Radiation Tomotherapy. National Student Research Forum, 2003.
57. Fuller CD, Cavanaugh SX, Eng TY. Dose Reduction via Balloon Displacement of Critical Structures. National Student Research Forum, 2003.
58. Voeltz L, Fuller CD, Salter BJ, Thomas CR. Dosimetric evaluation of extra-target doses using extracranial intensity modulated serial tomotherapy for abdominal neoplasms. Radiological Society of North America Annual Meeting, 2003.
59. Jones WE, Cavanaugh SX, Fuller CD, Eng TY. Merkel Cell Carcinoma Database. University of Texas Health Science Center at San Antonio Medical Student Research Day, 2003.
60. Fuller CD. QOL Research for Medical and Graduate Students. UTHSCSA Colloquium on Quality of Life, 2003.

Book Chapters

1. Fuller CD, Diehl AK. In: Biliary Tract and Gallbladder Cancer: Diagnosis and Therapy, 2008. ISBN: 9781933864426.
2. Czito B, Willett C, Fuller CD. In: Biliary Tract and Gallbladder Cancer: Diagnosis and Therapy, 2008. ISBN: 9781933864426.
3. Fuller CD, Thomas, CR. In: Biliary Tract and Gallbladder Cancer: Diagnosis and Therapy, Demos Medical Publishing, 2008. ISBN: 9781933864426.
4. Hung AY, Eng TY, Scarbrough TJ, Fuller CD, Thomas CR. In: Perez and Brady's Principles and Practice of Radiation Oncology, Fifth Edition, Lippincott Williams & Wilkins, 2007. ISBN: 978-078176369.
5. Eng TY, Boersma MGK, Fuller CD. In: Skin Cancer: New Research (Horizons in Cancer Research, Volume 31), Hauppauge NY, Nova Science Publishers, 2007. ISBN: 1600210961.

Books (edited and written)

1. Thomas CR, Fuller CD. Biliary Tract and Gallbladder Cancer: Diagnosis and Therapy, Demos Medical Publishing, 2008. ISBN: 9781933864426.

Letters to the Editor

1. Garden AS, Fuller CD. Letter to the Editor regarding transoral laser microsurgery followed by radiotherapy in advanced oropharyngeal cancer. Head Neck 36(11):1674-5, 11/2014. e-Pub 9/2014. PMCID: PMC4505609.

Manuals, Teaching Aids, Other Teaching Publications

1. Fuller CD. Target Contour Testing/Instructional Computer Software (TaCTICS): A Novel Training and Evaluation Platform for Radiotherapy Target Delineation http://skynet.ohsu.edu/tactics/, 7/2005.

Grant & Contract Support

Title: Bayesian Phase II Trial of MR-Guided Adaptive Radiotherapy
Funding Source: Head and Neck SPORE Developmental
Role: Sub-Awardee
Duration: 5/1/2016 - 4/30/2017
 
Title: Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Establish Objective Clinical Outcome Measures for Mandibular Osteoradionecrosis
Funding Source: NIH/NIDCR
Role: Co-Investigator
Principal Investigator: Stephen Lai
Duration: 4/1/2016 - 3/21/2021
 
Title: Pre-clinical study of active magnetic field biological influence on radiation responses of human solid cancers
Funding Source: Elekta Limited
Role: Co-Principal Investigator
Principal Investigator: Clifton D. Fuller
Duration: 7/1/2013 - 6/30/2014

Last updated: 7/28/2016